Análisis opcionales del producto
Con tu permiso, usamos análisis limitados y respetuosos con la privacidad para entender qué recorridos de investigación funcionan. No usamos rastreadores publicitarios ni grabación de sesiones. Puedes cambiar esta opción en Preferencias. Lee la Política de privacidad.
Citigroup Inc.'s published Sell conclusion compares the analysis-date price with fair value and potential value. Read the full report for assumptions, evidence, and material risks.
| Market cap | $231.0B | |
|---|---|---|
| Revenue (ttm) | 83.3B | |
| Net income (ttm) | 17.9B | |
| EPS (ttm) | $10.2 | |
| Shares out | 1.7B | |
| P/E (trailing) | 12.2x | |
| P/E (forward) | 10.6x | |
| Dividend | $2.68 (2.16%) | |
| Volume | 4,504,854 | |
| Beta | 1.11 |
Recent price action with selectable time range.
| Item | P1 | P2 | P3 | P4 | P5 | Trend |
|---|---|---|---|---|---|---|
| Period | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | Trend |
| Revenue | $71.88B | $75.34B | $78.07B | $80.72B | $85.23B | +4.3% |
| Gross profit | $75.78B | $69.37B | $67.90B | $71.12B | $75.05B | -0.2% |
| Operating income | $27.47B | $18.81B | $12.91B | $17.05B | $19.83B | -7.8% |
| Net income | $21.95B | $14.85B | $9.23B | $12.68B | $14.31B | -10.2% |
| EPS (diluted) | $10.14 | $7.00 | $4.04 | $5.94 | $6.99 | -8.9% |
| EBITDA | $31.43B | $23.07B | $17.47B | $21.36B | $24.20B | -6.3% |
| R&D | — | — | — | — | $2.33B | — |
| SG&A | $25.25B | $26.75B | $29.32B | $28.63B | $29.73B | +4.2% |
Recent company headlines from major financial publishers.
The base path accepts the estimate-backed recovery but does not extend it indefinitely. It would weaken if post-FY2027 profitability fails to normalize or regional concentration rises materially.
Upside persists only if post-FY2027 earnings growth proves durable and the observed regional revenue breadth translates into steadier profit. Rising diluted shares or renewed margin weakness would disconfirm this path.
| Ke ↓ / g → | 1.5% | 2.0% | 2.5% | 3.0% | 3.5% |
|---|---|---|---|---|---|
| 7.2% | $103 | $104 | $105 | $106 | $108 |
| 8.2% | $92.2 | $92.2 | $92.2 | $92.1 | $92.0 |
| 9.2% | $83.9 | $83.5 | $82.9 | $82.2 | $81.4 |
| 10.2% | $77.3 | $76.5 | $75.7 | $74.7 | $73.6 |
| 11.2% | $71.7 | $70.8 | $69.9 | $68.8 | $67.5 |
Upcoming earnings date and setup when available.
La calificación que llevaba la edición de análisis publicada cada mes. Una calificación compara el precio en la fecha del análisis con el valor razonable; no es un registro de si la valoración acertó.
| Año | ene | feb | mar | abr | may | jun | jul | ago | sept | oct | nov | dic |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 |